Arax Advisory Partners’s DexCom DXCM Stock Holding History

Arax Advisory Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42M	Buy	21,139 +16,760	+383%	+$1.12M	0.01%	1011
2026 Q1	$275K	Sell	4,379 -513	-10%	-$35.7K	0.01%	920
2025 Q4	$303K	Sell	4,892 -9,843	-67%	-$636K	0.01%	823
2025 Q3	$992K	Buy	14,735 +13,764	+1,418%	+$1.09M	0.01%	646
2025 Q2	$87.6K	Buy	971 +506	+109%	+$39.7K	﹤0.01%	991
2025 Q1	$31.8K	Sell	465 -2,288	-83%	-$187K	﹤0.01%	1116
2024 Q4	$214K	Buy	2,753 +2,557	+1,305%	+$189K	0.01%	468
2024 Q3	$13.1K	Hold	196	–	–	﹤0.01%	1285
2024 Q2	$22.2K	Buy	+196	New	+$24.8K	﹤0.01%	933
2022 Q3	–	Sell	-8	Closed	-$1K	–	1222
2022 Q2	$1K	Hold	8	–	–	﹤0.01%	1032
2022 Q1	$1K	Hold	8	–	–	﹤0.01%	1023
2021 Q4	$1K	Hold	8	–	–	﹤0.01%	996
2021 Q3	$1K	Buy	+8	New	+$1.01K	﹤0.01%	893
2020 Q4	$1K	Buy	+16	New	+$1.43K	﹤0.01%	694

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Arax Advisory Partners's DXCM Position: Q2 2026 in Review

Arax Advisory Partners increased its DexCom (DXCM) stake by 383% in Q2 2026, buying an estimated $1.12M and bringing the position to 21,139 shares worth $1.42M. The position accounts for 0.01% of the portfolio, ranked #1011.

Arax Advisory Partners first reported a position in DXCM in Q4 2020 and has held it in 14 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Arax Advisory Partners held 21,139 shares of DexCom worth $1.42M as of Q2 2026.
Arax Advisory Partners bought 16,760 DexCom shares in Q2 2026, an estimated $1.12M.
DexCom made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1011 holding.
Arax Advisory Partners first reported a position in DexCom in Q4 2020 and has held it in 14 quarters since.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.